Abacus Planning Group, Inc. Bristol Myers Squibb CO Transaction History
Abacus Planning Group, Inc.
- $552 Million
- Q1 2025
A detailed history of Abacus Planning Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 6,019 shares of BMY stock, worth $309,015. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,019
Previous 5,944
1.26%
Holding current value
$309,015
Previous $336,000
9.23%
% of portfolio
0.07%
Previous 0.06%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,775Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.75 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.15 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.93 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.88 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.1 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $109B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...